In Hirotsu Bio Science v. Assistant Controller of Patents and Designs, the Delhi High Court held that branding a process as “in vitro detection” does not rescue it from Section 3(i) when, in substance, it diagnoses cancer. The nematode-based urine test was thus refused as an excluded diagnostic method.
Read more about ‘In Vitro Detection’ Still Diagnostic: Nematode Cancer Test Barred under Section 3(i)Tag: Section 3(i) Patents Act
Section 3(i) and Diagnostic Patents: Court Upholds Refusal of Prenatal Testing Method
Delhi HC rules Sequenom’s NIPT methods are excluded as “diagnostic” under Section 3(i) and hit by 3(b) for sex selection concerns, while keeping the door open for tools and products.
Read more about Section 3(i) and Diagnostic Patents: Court Upholds Refusal of Prenatal Testing MethodPatent for Enzyme-Based Animal Feed Supplementation Cleared of Section 3(i) Refusal
The Madras High Court has allowed Kemin Industries’ patent on an enzyme-based animal feed method, overturning the Controller’s Section 3(i) refusal. The Court ruled that the method involves feed supplementation rather than treatment, confirming novelty and inventive step in the process.
Read more about Patent for Enzyme-Based Animal Feed Supplementation Cleared of Section 3(i) Refusal